Literature DB >> 17408712

Molecular cloning of serine proteases from elapid snake venoms.

Yang Jin1, Wen-Hui Lee, Yun Zhang.   

Abstract

Serine proteases are widely distributed in viperid snake venoms, but rare in elapid snake venoms. Previously, we have identified a fibrinogenolytic enzyme termed OhS1 from the venom of Ophiophagus hannah. The results indicated that OhS1 might be a serine protease, but there was no structural evidence previously. In the present study, the primary structure of OhS1 was determined by protein sequencing, in combination with RT-PCR and 5'-RACE methods. OhS1 precursor is composed of an 18-amino acid signal peptide, a 6-amino acid putative activation peptide and 236-amino acid mature protein. OhS1 homologues from Naja atra and Bungarus multicinctus were also cloned and reported. These elapid venom serine proteases exhibited approximately 60% sequence identity with serine proteases from the snake venoms of the Viperidae and Colubridae family. Phylogenetic analysis indicated that snake venom serine protease might have a common ancestor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408712     DOI: 10.1016/j.toxicon.2007.02.013

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  Phylogenetic analysis of serine proteases from Russell's viper (Daboia russelli siamensis) and Agkistrodon piscivorus leucostoma venom.

Authors:  Pattadon Sukkapan; Ying Jia; Issarang Nuchprayoon; John C Pérez
Journal:  Toxicon       Date:  2011-05-27       Impact factor: 3.033

2.  A novel serine protease from the snake venom of Agkistrodon blomhoffii ussurensis.

Authors:  Shuqing Liu; Ming-Zhong Sun; Changkai Sun; Baochang Zhao; Frederick T Greenaway; Qingyin Zheng
Journal:  Toxicon       Date:  2008-09-09       Impact factor: 3.033

3.  Many Options, Few Solutions: Over 60 My Snakes Converged on a Few Optimal Venom Formulations.

Authors:  Agneesh Barua; Alexander S Mikheyev
Journal:  Mol Biol Evol       Date:  2019-09-01       Impact factor: 16.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.